RNA Binding Proteins in Cancer
癌症中的 RNA 结合蛋白
基本信息
- 批准号:8444646
- 负责人:
- 金额:$ 28.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-01 至 2014-01-31
- 项目状态:已结题
- 来源:
- 关键词:3&apos Untranslated RegionsAffinityAnchorage-Independent GrowthApoptosisBehaviorBindingBinding SitesC-terminalCancer ModelCause of DeathCell DeathCell SurvivalCellsColon CarcinomaConsensusDeletion MutationDiseaseElementsEpidermal Growth FactorEpithelial CellsGene ExpressionGene Expression RegulationGenetic TranslationGlycineGoalsGrowthInterleukin-8IntestinesLeadMalignant NeoplasmsManuscriptsMediatingMessenger RNAMethodsMicroRNAsMitosisMitoticModificationMusMutagenesisN-terminalNormal CellNude MicePathway interactionsPhenotypePhosphorylationPost-Transcriptional RegulationProcessPromoter RegionsProtein BindingProtein OverexpressionProteinsProto-OncogenesPublishingRNA BindingRNA Recognition MotifRNA SequencesRNA StabilityRNA-Binding ProteinsRibonucleoproteinsRibosomesRoleSerineSignal PathwaySiteThreonineTranscriptTranscriptional ActivationTranslationsTyrosine Phosphorylation SiteUbiquitinationUnited StatesVascular Endothelial Growth FactorsWorkXenograft procedurebasecancer cellcyclooxygenase 2deletion analysishuman FRAP1 proteinmRNA DecaymRNA StabilitymTOR proteinmutantneoplastic cellnotch proteinnoveloverexpressionpromoterresearch studytumortumor xenografttumorigenesis
项目摘要
The broad goal of the project is to understand the mechanisms by which RNA binding
protein RBM3 regulates gene expression at the posttranscriptional level of mRNA
stability and translation in cancer cells. We have identified that overexpression of the
protein causes a normal cell to undergo a transformed phenotype resulting in the cells
forming tumors in immunocompromized mice. On the other hand, knockdown of RBM3
expression results in cell death due to mitotic catastrophe. RBM3 interacts with HuR and
hnRNP A1, and with AU-RNA sequences to enhance mRNA stability and translation of
AU-rich transcripts such as COX-2, VEGF and IL-8. In addition, RBM3 overexpression
increases the activation of the mammalian target of rapamycin protein in a Notch
dependent mechanism. We have also identified microRNAs regulated upon RBM3
overexpression, including downregulating one that inhibits its own expression. Our
studies also suggest that RBM3 is regulated at the posttranslational levels of
phosphorylation, ubiquitination and SUMOylation. Based on these observations, we
propose three specific aims. In Aim 1, we will determine the mechanism by which RNA
binding protein RBM3 regulates gene expression. Here, we will identify the RNA
sequences that interact with RBM3. In addition, we will determine the sequenced in
COX-2 3'UTR that are required for RBM3-mediated COX-2 mRNA stability and
translation. We will also identify the role of HuR and hnRNP-A1 in the process. In Aim 2,
we will determine the residues in RBM3 that undergo phosphorylation, ubiquitination and
SUMOylation by mutagenesis. We will also determine the effect of the mutants on
mRNA stability and translation. In Aim 3, we propose to determine the mechanisms by
which RBM3 induces tumorigenesis. We will use an xenograft cancer model to
determine the role of mTOR and Notch pathway in RBM3 mediated tumorigenesis. Also,
the role of microRNAs in the tumorigenesis will be determined. Completion of these
experiments should give us a better understanding of how the RNA binding protein
RBM3 functions in normal epithelial cells, and whether changes in the RBM3 expression
that is observed in tumor cells is responsible for tumor behavior.
该项目的总体目标是了解 RNA 结合的机制
蛋白 RBM3 在 mRNA 转录后水平调节基因表达
癌细胞中的稳定性和翻译。我们已经发现过度表达
蛋白质导致正常细胞发生转化表型,从而产生细胞
在免疫功能低下的小鼠中形成肿瘤。另一方面,RBM3的敲低
表达导致细胞因有丝分裂灾难而死亡。 RBM3 与 HuR 相互作用并且
hnRNP A1,并具有 AU-RNA 序列,可增强 mRNA 稳定性和翻译
富含 AU 的转录物,例如 COX-2、VEGF 和 IL-8。此外,RBM3过表达
增加Notch中雷帕霉素蛋白的哺乳动物靶标的激活
依赖机制。我们还鉴定了受 RBM3 调节的 microRNA
过度表达,包括下调抑制其自身表达的表达。我们的
研究还表明 RBM3 在翻译后水平受到调节
磷酸化、泛素化和SUMO化。根据这些观察,我们
提出三个具体目标。在目标 1 中,我们将确定 RNA 的机制
结合蛋白 RBM3 调节基因表达。在这里,我们将鉴定RNA
与 RBM3 相互作用的序列。此外,我们将确定排序
COX-2 3'UTR 是 RBM3 介导的 COX-2 mRNA 稳定性所必需的
翻译。我们还将确定 HuR 和 hnRNP-A1 在此过程中的作用。在目标 2 中,
我们将确定 RBM3 中经历磷酸化、泛素化和
通过诱变进行 SUMO 化。我们还将确定突变体对
mRNA 稳定性和翻译。在目标 3 中,我们建议通过以下方式确定机制:
RBM3 诱导肿瘤发生。我们将使用异种移植癌症模型
确定 mTOR 和 Notch 通路在 RBM3 介导的肿瘤发生中的作用。还,
microRNA在肿瘤发生中的作用将被确定。完成这些
实验应该让我们更好地了解 RNA 结合蛋白如何
RBM3 在正常上皮细胞中发挥作用,以及 RBM3 表达是否发生变化
在肿瘤细胞中观察到的这一现象是肿瘤行为的原因。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shrikant Anant其他文献
Shrikant Anant的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shrikant Anant', 18)}}的其他基金
6th Annual Midwest Tumor Microenvironment Meeting
第六届中西部肿瘤微环境年会
- 批准号:
10002411 - 财政年份:2020
- 资助金额:
$ 28.38万 - 项目类别:
Bitter Melon Component and Colon Cancer Prevention
苦瓜成分与预防结肠癌
- 批准号:
8796002 - 财政年份:2014
- 资助金额:
$ 28.38万 - 项目类别:
Novel Dual Notch/PXR Targeting for Colon Cancer Therapy
用于结肠癌治疗的新型双Notch/PXR靶向
- 批准号:
9198492 - 财政年份:2014
- 资助金额:
$ 28.38万 - 项目类别:
Novel Dual Notch/PXR Targeting for Colon Cancer Therapy
用于结肠癌治疗的新型双Notch/PXR靶向
- 批准号:
8627820 - 财政年份:2014
- 资助金额:
$ 28.38万 - 项目类别:
Bitter Melon Component and Colon Cancer Prevention
苦瓜成分与预防结肠癌
- 批准号:
9321795 - 财政年份:2014
- 资助金额:
$ 28.38万 - 项目类别:
Novel Dual Notch/PXR Targeting for Colon Cancer Therapy
用于结肠癌治疗的新型双Notch/PXR靶向
- 批准号:
9144740 - 财政年份:2014
- 资助金额:
$ 28.38万 - 项目类别:
RNA Binding Protein CUGBP2 in Intestinal Epithelium
肠上皮细胞中的 RNA 结合蛋白 CUGBP2
- 批准号:
7583130 - 财政年份:2009
- 资助金额:
$ 28.38万 - 项目类别:
RNA Binding Protein CUGBP2 in Intestinal Epithelium
肠上皮细胞中的 RNA 结合蛋白 CUGBP2
- 批准号:
7924796 - 财政年份:2009
- 资助金额:
$ 28.38万 - 项目类别:
相似海外基金
Impact of alternative polyadenylation of 3'-untranslated regions in the PI3K/AKT cascade on microRNA
PI3K/AKT 级联中 3-非翻译区的替代多聚腺苷酸化对 microRNA 的影响
- 批准号:
573541-2022 - 财政年份:2022
- 资助金额:
$ 28.38万 - 项目类别:
University Undergraduate Student Research Awards
How do untranslated regions of cannabinoid receptor type 1 mRNA determine receptor subcellular localisation and function?
1 型大麻素受体 mRNA 的非翻译区如何决定受体亚细胞定位和功能?
- 批准号:
2744317 - 财政年份:2022
- 资助金额:
$ 28.38万 - 项目类别:
Studentship
MICA:Synthetic untranslated regions for direct delivery of therapeutic mRNAs
MICA:用于直接递送治疗性 mRNA 的合成非翻译区
- 批准号:
MR/V010948/1 - 财政年份:2021
- 资助金额:
$ 28.38万 - 项目类别:
Research Grant
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
- 批准号:
10019570 - 财政年份:2019
- 资助金额:
$ 28.38万 - 项目类别:
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
- 批准号:
10223370 - 财政年份:2019
- 资助金额:
$ 28.38万 - 项目类别:
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
- 批准号:
10455108 - 财政年份:2019
- 资助金额:
$ 28.38万 - 项目类别:
Synergistic microRNA-binding sites, and 3' untranslated regions: a dialogue of silence
协同的 microRNA 结合位点和 3 非翻译区:沉默的对话
- 批准号:
255762 - 财政年份:2012
- 资助金额:
$ 28.38万 - 项目类别:
Operating Grants
Analysis of long untranslated regions in Nipah virus genome
尼帕病毒基因组长非翻译区分析
- 批准号:
20790351 - 财政年份:2008
- 资助金额:
$ 28.38万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Search for mRNA elements involved in the compatibility between 5' untranslated regions and coding regions in chloroplast translation
寻找参与叶绿体翻译中 5 非翻译区和编码区之间兼容性的 mRNA 元件
- 批准号:
19370021 - 财政年份:2007
- 资助金额:
$ 28.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Post-transcriptional Regulation of PPAR-g Expression by 5'-Untranslated Regions
5-非翻译区对 PPAR-g 表达的转录后调控
- 批准号:
7131841 - 财政年份:2006
- 资助金额:
$ 28.38万 - 项目类别:














{{item.name}}会员




